AC
BFT

Apogem Capital’s Foley Trasimene Acquisition Corp. II BFT Stock Holding History

Apogem Capital’s Portfolio BFT Stock Details BFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-27,634
Closed -$417K – 231
2020
Q4 		$417K Buy
+27,634
New +$315K 0.28% 110

Other funds holding BFT

DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
EWM
Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Apogem Capital's BFT Position: Q1 2021 in Review

Apogem Capital sold out of Foley Trasimene Acquisition Corp. II (BFT) in Q1 2021, closing a stake of 27,634 shares — an estimated $417K sold.

Apogem Capital first reported a position in BFT in Q4 2020 and held it in 1 quarter. The position peaked at $417K in Q4 2020. 3 funds tracked by Wall St. Rank hold BFT as of Q1 2021.

  • Apogem Capital reported no remaining Foley Trasimene Acquisition Corp. II position as of Q1 2021 after selling out during the quarter.
  • Apogem Capital sold 27,634 Foley Trasimene Acquisition Corp. II shares in Q1 2021, an estimated $417K.
  • Apogem Capital first reported a position in Foley Trasimene Acquisition Corp. II in Q4 2020 and held it in 1 quarter.
  • Apogem Capital's Foley Trasimene Acquisition Corp. II position peaked at $417K in Q4 2020.
  • 3 funds tracked by Wall St. Rank held Foley Trasimene Acquisition Corp. II as of Q1 2021.

Based on Apogem Capital's 13F filing for Q1 2021, filed 14 May 2021.